BIOSTOCK LIFE SCIENCE SUMMIT

It is once again time for the BioStock Life Science Spring Summit! During the packed two-day event, several compelling life science companies will showcase their projects and innovations to investors and potential partners. Additionally, industry experts and investors will offer their valuable advice and experiences during the expert insights session(s) of the event.

STUDIO

Erik Digman Wiklund, CEO Circio

Circio’s CEO on the new strategy

Circio, formerly known as Targovax, is a Norwegian immunotherapy company within RNA-based therapeutics. The company is focusing on circular RNA, which holds several advantages...
CombiGenes vd Jan Nilsson i BioStocks tv-studio i Sotckholm

Status update from CombiGene’s CEO

Curasight comments the Curium deal

Curasight on the agreement with Curium

AlligatorBioscienceCEOinterview_SørenBregenholt

Alligator Bioscience’s CEO on the rights issue

Soren Bregenholt, CEO Alligator Bioscience

BioStock Investor Pitch: Alligator Bioscience

Load more

RECOMMENDED READING

Curasight recently published its Q1 report for 2023

Curasight solidifies position with Curium deal and strong financials

Copenhagen-based biotechnology company Curasight recently released its Q1 2023 report, unveiling a significant stride...
Iconovo

Iconovo initiates structured sales process for ICOpre

Iconovo is currently in negotiations with global pharmaceutical companies regarding the company's latest developed...
New Opportunities for BiBBInstruments

Full speed ahead for BiBBInstruments after FDA clearance

Alligator orphan drug designation

Alligator Bioscience awarded Orphan Drug Designation for mitazalimab

Elicera Q1 2023

Well-financed Elicera prepared for clinic and business development

Strengthened team and cash position for Dicot

Dicot heading towards summer with strengthened team and finances

EVENT

© BioStock 2023